ETO STERILISATION
METHODS, REQUIREMENTS & TESTING
By
BUSINESS MANAGEMENT CONSULTANTS INT’L
in collaboration with
Tti Testing Laboratories Lahore
WWW.BMCI.PK info@bmci.pk
SHAUKAT ALI Cell. 0333-8612798
Regulatory and Management Consultant
Introduction
Sterilization
Process used to transform product free from
viable microorganisms
Microorganisms
Bacteria
Viruses
Fungi
Introduction
Why sterilization is needed?
Medical device is
assembled in controlled
t ll d
environment,
but may contain
microorganisms
Introduction
Why sterilization is needed?
Microorganisms may cause infection
Invasive devices enter normally sterile body tissue
Introduction
Sterilization purpose
To inactivate the microorganisms
Transform the medical device into sterile
Introduction
Inactivation of microorganisms
D value:
Time required to
achieve inactivation of
90% of a population of
the microorganism
under specific conditions
Sterlity ?
The absence of microorganisms cannot be proven
A sterility assurance level (SAL) is used to define
the sterility
Sterlity
Sterility Assurance Level (SAL)
Probability of a
viable organism
being present
on a product unit
after sterilization
SAL of 10-6 is required
by the FDA for
invasive medical
device
Sterlization Methods
Sterilization Methods
Steam Sterilization (Moist Heat)
Eto Sterilization
Gamma Radiation Sterilization
ETO Sterlization
Ethylene oxide (ETO)
Colorless flammable gas
Chemically reactive
Irritating, carcinogenic, mutagenic gas
Alkylation reaction cause damage to DNA
and proteins of microorganisms
ETO Sterlization
ETO processing steps
1. Preconditioning/conditioning
Exposure to relative humidity and temperature
Ensure uniformity of conditions
2. Sterilization cycle
Exposure to ETO gas
3. Aeration
Dissipation of remaining gases
ETO Sterlization
Process parameters
1. Gas quantity
>400mg/L
2. Temperature
~45ºC
3.Relative humidity
~35 – 80%
4. Exposure time
~90 – 360 minutes
ETO Sterlization
Advantages
Most product and packaging are compatible materials
Relatively low temperature process
Disadvantages
Penetration sometimes difficult
Residuals
Long process and release time
ETO Sterlization Process Map (Courtesy MSS)
Gamma Radiation Sterlization
Gamma radiation
Electromagnetic radiation of short wavelength
High-energy photons are emitted from an isotope
(Cobalt 60)) source producing
so rce prod cing ionization throughout
ioni ation thro gho t a
product
Cause damage to DNA and cellular structures of
microorganisms
Radiation dose is measured in kGy values
Gamma Radiation Sterlization
Gamma radiation effects on materials
Brittle
Color
Odor
Stiffness
Softens
Toxicity
Chemical
inertness
Melt temperature
Gamma Radiation Sterlization
Advantages
Deep penetration power
No residuals
Only one process parameter – time
Low temperature process
Release immediately after sterilization
Disadvantage
Not all product and packaging materials compatible
Sterilization validation
Documented procedure for obtaining, recording and
interpreting the results required to establish that a
process will consistently yield product complying
with predetermined specifications
SAL of 10-6 shall be demonstrated
Sterilization validation
Objectives
The sterilization process will consistently achieve sterility
The sterilization process will not have an adverse impact
on the device or its packaging
ETO sterilization validation
Applicable standards
ANSI/AAMI/ISO 11135-1:2007
“Sterilization of health care products – Ethylene oxide -
Part 1: Requirements for the development, validation and
routine control of a sterilization process for medical
devices”
ANSI/AAMI/ISO 11135-2:2008
“Sterilization of health care products – Ethylene oxide -
Part 2: Guidance on the application of ISO 11135-1”
ETO sterilization validation
ETO validation overview
Process and equipment characterization
IQ (Installation Qualification)
OQ (Operational Qualification)
Product definition
PQ (Performance Qualification) – Physical
PQ (Performance Qualification) – Microbiological
Documentation
Revalidation
ETO sterilization validation
IQ - Installation Qualification
IQ shall demonstrate that the sterilization
equipment have been installed in accordance with
their specification
OQ – Operational Qualification
OQ shall demonstrate that the installed equipment is
capable of delivering the specified process within
defined tolerances
ETO sterilization
ETO sterilization validation
validation
Product definition
Product families
Product configuration
Product and packaging materials
Density
Manufacturing environment
Bioburden
PCD (Product Challenge Device)
ETO sterilization validation
PQ - Performance Qualification
PQ shall use product or PCD to demonstrate that:
Equipment consistently operates in accordance
with predetermined criteria
The process produces product that is sterile
ETO sterilization validation
PQ – Physical
Physical PQ shall confirm the predetermined process
parameters throughout the load, for the duration of the
sterilization process
PQ - Microbiological
Microbiological PQ shall confirm the effectiveness of
the defined process in achieving the required SAL, for
product/load combination
ETO sterilization validation
PQ - Physical
The physical PQ can be performed in parallel with the
microbiological PQ
During sterilization process parameters are
monitored:
Temperature
Relative humidity
Pressure
Process parameters are within the required range
ETO sterilization validation
PQ –
Microbiological
Determination of lethal rate of the sterilization
process, according to one of the approaches:
1. Cycle calculation approach
Cycle
C l parameters t that
th deliver
t d li minimally
i i ll 12 log
l reduction
d ti
shall be calculated
2. Half cycle approach
3 half cycles resulting in 6 log reduction shall be
performed
ETO sterilization validation
PQ – Microbiological
Bioburden estimation
Validation cycles according to half cycle approach
Fractional cycle
3 x Half cycles
Full cycle
Sterilized samples testing
ETO residual testing
ETO sterilization validation
Bioburden estimation
Population of viable microorganisms on or in the
product
Test non-sterilized samples
Bioburden <100 CFU/product is considered relatively
low
If bioburden > 1000 CFU/product the cleanness level
of the manufacturing environment should be improved
ETO sterilization validation
Validation Cycles
a. Fractional cycle
b. 3 x Half cycles
c. Full cycle
ETO sterilization validation
Biological Indicators (BI)
Test system containing 106 viable microorganisms to
ensure SAL of 10-6
BI must be inserted in the most difficult location to
sterilize in the product
Discs and Wires
Paper Strips
Gl
Glass A l
Ampoule
ETO sterilization validation
Fractional cycle
Products inoculated with BIs Products
BI Sterility Test Product Sterility Test
BI product
X BIs show GROWTH If X>Y Y products show GROWTH
The BI is more resistant to the sterilization
process, compared to the bioburden
ETO sterilization validation
Half cycle
Presents worst case scenario
Samples inoculated with BIs are subjected to half
cycle
Following sterilization, BIs are removed from the
samples and tested for BI sterility
All BIs should show NO GROWTH
ISO 11135: 3 half cycles must be run
ETO sterilization validation
Full cycle
One full cycle is required
Samples inoculated with BIs are subjected to full cycle
All BIs should show NO GROWTH
ETO residual testing
ETO sterilization validation
ETO residual testing
ETO is known to exhibit a number of biological effects:
1. Irritation
2. Mutagenicity
3. Carcinogenicity
ETO residual quantity is effected by product,
ETO residual
packaging quantity
and processis characteristics
effected by product
The ETO residuals should meet the acceptance
criteria according to ISO 10993-7
Aeration may be prolonged
ETO sterilization validation
Revalidation
Annually the status of the sterilization validation must be
reviewed
Inspection of:
Bioburden
Product design and packaging
Process equipment and parameters
Revalidation usually consist one half cycle and one full
cycle
ETO sterilization validation
Product definition
Product families
Bioburden
Size of product
No. of components
Complexity of product
Manufacturing environment
ETO sterilization validation – Additional Tests
Additional tests for sterilized products
The sterilization process will not have an adverse impact
on the device or its packaging:
Product functionality
Packaging integrity
Visual inspection
Peel test
Dye penetration test
Sterilization validation
Maintaining process effectiveness
Routine monitoring of product bioburden
bioburden
Maintenance of the sterilization equipment
Instrumentation used to monitor and control
process parameters should be calibrated
Sterilization validation
Assessment of change
1. A change to equipment, product, packaging, or loading pattern
2. Effect on effectiveness of the sterilization process
3. Effect on IQ, OQ or PQ validations
4. Documented rationale for decisions reached
ISO Standards for ETO Sterilization
ISO 11135-1:2007
Sterilization of health care products -- Ethylene oxide -- Part 1: Requirements for
development, validation and routine control of a sterilization process for medical devices
ISO/TS 11135-2:2008
Sterilization of health care products -- Ethylene oxide -- Part 2: Guidance on the application
of ISO 11135-1
ISO 10012:2003
Measurement management systems -- Requirements for measurement processes and
measuring equipment
ISO 11138-1:2006
Sterilization of health care products -- Biological indicators -- Part 1: General requirements
ISO 11138-2:2006
Sterilization of health care products -- Biological indicators -- Part 2: Biological indicators
for ethylene oxide sterilization processes
ISO 11140-1:2005
Sterilization of health care products -- Chemical indicators -- Part 1: General requirements
ISO Standards for ETO Sterilization
2006
Sterilization of medical devices -- Microbiological methods -- Part 1: Determination of a population
of microorganisms on products
ISO 11737-2:2009
Sterilization of medical devices -- Microbiological methods -- Part 2: Tests of sterility performed in
the definition, validation and maintenance of a sterilization process
ISO 14161:2009
Sterilization of health care products -- Biological indicators -- Guidance for the selection, use and
interpretation of results
ISO 14937:2009
Sterilization of health care products -- General requirements for characterization of a sterilizing
agent and the development, validation and routine control of a sterilization process for medical
devices
ISO 11607-1:2006
Packaging for terminally sterilized medical devices -- Part 1: Requirements for materials, sterile
barrier systems and packaging systems
ISO 11607-2:2006
Packaging for terminally sterilized medical devices -- Part 2: Validation requirements for forming,
sealing and assembly processes
Summary
1. Sterilization process is crucial for patient safety
2. Validation is required to establish that a process will
consistently yield SAL of 10-6
3. process effectiveness must be maintained
4. Any change to product design or packaging shall be
assessed
5. ETO Residue Test as per ISO 10993-7 should be performed
for establishing safety of product /Medical Device.
Any questions?
Questions?